Rapid Weight Gain During Mirtazapine Treatment
Case Report
A 19-year-old Taiwanese man was admitted for psychiatric inpatient treatment because of major depressive disorder. The patient had presented the characteristic symptoms of depressed mood, loss of interest, anorexia, insomnia, and feelings of worthlessness in the preceding 2 months. He had been healthy in the past, without systemic disease such as metabolic disease. Initial laboratory studies revealed random blood glucose, 73 mg/dl (reference range: 70–105 mg/dl), and the thyroid function examination results were all within the normal range. He weighed 80.5 kg and scored 28 on the 17-item Hamilton Depression Rating Scale (Ham-D) on the first hospital day. Initially, he was treated with paroxetine, 20 mg/day, and zolpidem, 10 mg/night, for 14 days. His symptoms of depressed mood, anorexia, and marked insomnia were little improved. Also, he lost 4 kgs in 14 days. After this, treatment with paroxetine was discontinued, and mirtazapine, 30 mg, was prescribed at night. The patient's mood improved, but he also experienced intermittent headaches, increased appetite, and weight gain—6.5 kgs in 1 week. His Ham-D total score improved to 7 in that same week of mirtazapine therapy.
Discussion
Drug-induced weight gain is a serious problem with most psychotropic drugs, and it may be associated with health risks such as metabolic syndrome, cardiovascular disease, and type 2 diabetes. Weight gain associated with mirtazapine treatment has been reported and may be accounted for by its effects on 5HT2C and H1 receptors. The patient's rapid weight gain of 6.5 kg in 1 week of mirtazapine therapy is much faster than has been reported in the literature. Meanwhile, a significant improvement in the Ham-D total score was noted during this period. The possible mechanism of the initial weight gain associated with mirtazapine could be a direct effect due to the antihistaminic (H1) effects or early antidepressant action to improve appetite. In the future, it would be of interest to undertake a study of potential differential effects of mirtazapine versus other antidepressants, such as selective serotonin reuptake inhibitors, in the relationships of weight gain and Ham-D total score.
1. : The pharmacological profile of mirtazapine. J Clin Psychiatry 1995; 57(suppl 4):19–26Google Scholar
2. : Mirtazapine in the treatment of adolescent anorexia nervosa: case-control study. Eur Child Adolesc Psychiatry 2008; 17:187–189Crossref, Medline, Google Scholar
3. : Effectiveness of mirtazapine for nausea and insomnia in cancer patients with depression. Psychiatry Clin Neurosci 2008; 62:75–83Crossref, Medline, Google Scholar
4. : Glucose dysregulation and mirtazapine-induced weight gain. Am J Psychiatry 2003; 160:797Crossref, Medline, Google Scholar